Net profit surged 41.6% YoY in 3Q24, driven by health insurance growth and strong investment returns. CSM balance rose to W13tn, while shareholders' equity declined due to regulatory changes. FY24 guidance targets further health market expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.